Carta Produção Nacional Revisado por pares

Interim results from a large multinational extension trial (guardian ™ 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

2016; Wiley; Volume: 22; Issue: 5 Linguagem: Inglês

10.1111/hae.12990

ISSN

1365-2516

Autores

Steven R. Lentz, M. Cerqueira, Dragana Janić, Christine L. Kempton, Irina Matytsina, Mudi Misgav, Johannes Oldenburg, Margareth C. Ozelo, Michael Recht, Anders Rosholm, Aleksandar Savić, Takashi Suzuki, Andreas Tiede, Elena Santagostino,

Tópico(s)

Platelet Disorders and Treatments

Resumo

HaemophiliaVolume 22, Issue 5 p. e445-e449 Letter to the Editor Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A S. R. Lentz, Corresponding Author S. R. Lentz steven-lentz@uiowa.edu The University of Iowa Carver College of Medicine, Iowa City, IA, USA Correspondence: S. R. Lentz, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. Tel.: 319-356-1616; fax: 319-353-8383; e-mail: steven-lentz@uiowa.eduSearch for more papers by this authorM. Cerqueira, M. Cerqueira HEMORIO, Rio De Janeiro, BrazilSearch for more papers by this authorD. Janic, D. Janic School of Medicine, University of Belgrade, University Children's Hospital, Belgrade, SerbiaSearch for more papers by this authorC. Kempton, C. Kempton Department of Hematology/Oncology, Emory University School of Medicine, Atlanta, GA, USASearch for more papers by this authorI. Matytsina, I. Matytsina Novo Nordisk A/S, Soeborg, DenmarkSearch for more papers by this authorM. Misgav, M. Misgav National Hemophilia Center, Chaim Sheba Medical Center, Tel Aviv University, Ramat-Gan, IsraelSearch for more papers by this authorJ. Oldenburg, J. Oldenburg Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, GermanySearch for more papers by this authorM. Ozelo, M. Ozelo IHTC 'Claudio L.P. Correa', INCT do Sangue Hemocentro UNICAMP, University of Campinas, Sao Paulo, BrazilSearch for more papers by this authorM. Recht, M. Recht The Hemophilia Center, Oregon Health & Science University, Portland, OR, USASearch for more papers by this authorA. Rosholm, A. Rosholm Novo Nordisk A/S, Soeborg, DenmarkSearch for more papers by this authorA. Savic, A. Savic Clinic of Hematology, Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, SerbiaSearch for more papers by this authorT. Suzuki, T. Suzuki Department of Laboratory Medicine, Tokyo Medical University, Tokyo, JapanSearch for more papers by this authorA. Tiede, A. Tiede Hannover Medical School, Hannover, GermanySearch for more papers by this authorE. Santagostino, E. Santagostino Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital Policlinico, Milan, ItalySearch for more papers by this author S. R. Lentz, Corresponding Author S. R. Lentz steven-lentz@uiowa.edu The University of Iowa Carver College of Medicine, Iowa City, IA, USA Correspondence: S. R. Lentz, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. Tel.: 319-356-1616; fax: 319-353-8383; e-mail: steven-lentz@uiowa.eduSearch for more papers by this authorM. Cerqueira, M. Cerqueira HEMORIO, Rio De Janeiro, BrazilSearch for more papers by this authorD. Janic, D. Janic School of Medicine, University of Belgrade, University Children's Hospital, Belgrade, SerbiaSearch for more papers by this authorC. Kempton, C. Kempton Department of Hematology/Oncology, Emory University School of Medicine, Atlanta, GA, USASearch for more papers by this authorI. Matytsina, I. Matytsina Novo Nordisk A/S, Soeborg, DenmarkSearch for more papers by this authorM. Misgav, M. Misgav National Hemophilia Center, Chaim Sheba Medical Center, Tel Aviv University, Ramat-Gan, IsraelSearch for more papers by this authorJ. Oldenburg, J. Oldenburg Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, GermanySearch for more papers by this authorM. Ozelo, M. Ozelo IHTC 'Claudio L.P. Correa', INCT do Sangue Hemocentro UNICAMP, University of Campinas, Sao Paulo, BrazilSearch for more papers by this authorM. Recht, M. Recht The Hemophilia Center, Oregon Health & Science University, Portland, OR, USASearch for more papers by this authorA. Rosholm, A. Rosholm Novo Nordisk A/S, Soeborg, DenmarkSearch for more papers by this authorA. Savic, A. Savic Clinic of Hematology, Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, SerbiaSearch for more papers by this authorT. Suzuki, T. Suzuki Department of Laboratory Medicine, Tokyo Medical University, Tokyo, JapanSearch for more papers by this authorA. Tiede, A. Tiede Hannover Medical School, Hannover, GermanySearch for more papers by this authorE. Santagostino, E. Santagostino Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital Policlinico, Milan, ItalySearch for more papers by this author First published: 13 June 2016 https://doi.org/10.1111/hae.12990Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume22, Issue5September 2016Pages e445-e449 RelatedInformation

Referência(s)
Altmetric
PlumX